CYP2D6 genotype and venlafaxine-XR concentrations in depressed elderly

International Journal of Geriatric Psychiatry
Ellen M WhyteBruce G Pollock

Abstract

The elderly are at increased risk for medication-related adverse events. Recent reports indicate that venlafaxine may put the elderly at increased risk of cardio- and cerebrovascular adverse events. We investigated the relationship between the CYP2D6 polymorphism and steady-state plasma concentration of venlafaxine (VEN) and its primary metabolite o-desmethylvenlafaxine (ODV) in elderly participants receiving venlafaxine-XR for major depression in order to explore the contribution of pharmacogenetics to medication tolerability. Forty-six elderly participants received venlafaxine-XR for the treatment of major depression. CYP2D6 genotype and steady-state plasma levels of VEN and ODV were determined. Sixty-five percent of participants were homozygous of the wild type (WT) allele, whereas 35% carried one or more variant alleles associated with intermediate and poor 2D6 metabolizer status. VEN concentration per unit dose was significantly higher and ODV concentration per unit dose was significantly lower in participants who carried one or more variant alleles compared to participants who were homozygous for the WT allele. The VEN and ODV concentrations per unit dose were also correlated with creatinine clearance. CYP2D6 genotype was...Continue Reading

References

Sep 27, 1975·Lancet·M H Gault, D W Cockcroft
Nov 1, 1975·Journal of Psychiatric Research·M F FolsteinP R McHugh
Jan 1, 1976·Nephron·D W Cockcroft, M H Gault
Jan 1, 1992·Nephron·M H GaultC Wesolowski
Dec 1, 1967·The British Journal of Social and Clinical Psychology·M Hamilton
Jan 14, 2000·Pharmacogenetics·E LessardJ Turgeon
Mar 29, 2001·Journal of Clinical Psychopharmacology·F LederbogenM Deuschle
Jun 26, 2001·International Journal of Geriatric Psychiatry·B H MulsantUNKNOWN PROSPECT Study Group
Oct 30, 2001·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·G M MurphyC F Reynolds
Sep 28, 2002·Journal of Clinical Psychopharmacology·LalithKumar K SolaiCharles F Reynolds
Dec 7, 2002·BMJ : British Medical Journal·Nicholas A Buckley, Peter R McManus
Sep 30, 2003·The American Journal of Psychiatry·Greer M MurphyAlan F Schatzberg
Apr 30, 2004·Clinical Pharmacology and Therapeutics·Thomas RauThomas Eschenhagen
May 4, 2004·The American Journal of Psychiatry·Anil K MalhotraJames L Kennedy
Jan 12, 2005·The Journal of Clinical Psychiatry·Ellen M WhyteCharles F Reynolds
Jul 20, 2005·Journal of Clinical Psychopharmacology·Bruce G Pollock

❮ Previous
Next ❯

Citations

May 1, 2010·International Journal of Legal Medicine·Terhi LauniainenIlkka Ojanperä
Oct 13, 2009·Clinical Pharmacokinetics·Shu-Feng Zhou
Nov 12, 2009·Clinical Pharmacokinetics·Shu-Feng Zhou
Apr 5, 2011·Cleveland Clinic Journal of Medicine·Joseph P KitzmillerWolfgang Sadee
Oct 25, 2013·International Review of Psychiatry·C Anthony AltarDavid Mrazek
Feb 25, 2015·International Journal of Molecular Sciences·Teri SmithMerlin G Butler
Jun 12, 2009·Drug Metabolism Reviews·Shu-Feng ZhouBalram Chowbay
Jul 9, 2011·Expert Opinion on Drug Metabolism & Toxicology·Stefano PorcelliDiana De Ronchi
Jul 16, 2013·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Chiara FabbriAlessandro Serretti
Apr 4, 2007·The American Journal of Medicine·David B GoldsteinSanjay M Sisodiya
Sep 1, 2006·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Ellyn M JohnsonCharles F Reynolds
Oct 29, 2013·Pharmacology, Biochemistry, and Behavior·Olivia F O'LearyJohn F Cryan
May 20, 2015·Current Psychiatry Reports·Chiara Fabbri, Alessandro Serretti
Sep 10, 2014·Journal of Neural Transmission·Edoardo Spina, Jose de Leon
Aug 17, 2016·International Journal of Molecular Sciences·Aizati N A DaudBob Wilffert
Dec 6, 2008·Journal of Psychiatric Practice·Sheldon H PreskornChristine J Guico-Pabia
Aug 2, 2019·Pharmacogenomics·Justyna SuwałaAnna Wiela-Hojeńska
Mar 13, 2014·Drug Metabolism and Drug Interactions·Paulo MagalhãesAmílcar Falcão
Oct 17, 2013·Pharmacogenetics and Genomics·Katrin SangkuhlTeri E Klein
Sep 21, 2005·Journal of Clinical Pharmacology·Francis E Lotrich, Bruce G Pollock
Oct 13, 2020·Journal of Clinical Psychopharmacology·Lauren M BehlkeBenoit H Mulsant
Jul 22, 2021·Research in Gerontological Nursing·Ben R Inventor, Olimpia Paun

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.